Skip to main content
Susanne Goldstein, MD, Neurology, Silver Spring, MD

SusanneRachelGoldsteinMD

Neurology • Silver Spring, MD

Movement Disorder

Medical Officer, FDA/CDER/DNP

Join to view full profile

Dr. Goldstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Goldstein's full profile

Already have an account?

Education & Training

  • Duke University/NIH
    Duke University/NIHMHS, 1988 - 2000
  • Brown University
    Brown UniversityResidency, Neurology, 1993 - 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1992 - 1993
  • The Warren Alpert Medical School of Brown University
    The Warren Alpert Medical School of Brown UniversityClass of 1992
  • Brown University
    Brown UniversityB.A., 1985

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2000 - 2024
  • RI State Medical License
    RI State Medical License 1994 - 2000
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Journal Articles

  • Prevalence of Anxiety Disorders and Anxiety Subtypes in Patients with Parkinson’s Disease  
    Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsh ES, Lemann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L, Move Disord, 7/1/2009
  • Adult-onset primary lower limb dystonia  
    Schneider SA, Edwards MJ,Grill SE, Goldstein S, Knachana S, Quinn NP, Bhatia KP, Hallett M, Reich SG, Mov Disord, 1/1/2006
  • Pilot Trial of 1-Octanol in Essential Tremor  
    Bushara KO, Goldstein SR, Grimes, GJ, Bernstein A, Hallett, M, Neurology, 1/1/2003
  • Join now to see all

Books/Book Chapters

  • Diseases of the Central Nervous System 
    Chapter: Dystonia 
    Karp, BI, Goldstein S, Hallett MEditors: Asbury A, McKhann G, McDonald WI, Goadsby PJ, McArthur JC.Cambridge University PressEdition Thir,2002

Abstracts/Posters

  • Prevalence and comorbidity of psychiatric diagnoses in a community-based sample of patients with Parkinson’s disease (PD)
    Marsh, L, Hirsh ES, Anderson, KE, Goldstein, SR, Grill, S, Lehmann S, Little, JT, Margolis, RL, Palanci, J, Pontone, GM, Rabins, PV, Weiss, HW, Williams, JR, 24th Annual PSG Symposium on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Movement Disorders, Irving, TX, 5/15/2010
  • Clozapine for the treatment of generalized and focal dystonia
    Goldstein SR, Karp BI, Sami A, Chen R, Bara-Jiminez W, Hallett M, 5th International Congressof Parkinson’s Disease and Movement Disorders, New York, 10/13/1998
  • Substituting olanzapine for clozapine in Parkinson’s disease patients with drug-induced psychosis
    Friedman JH, Goldstein SR, Jacques, European Society for Clinical Neuropharmacology, Eliat, Israel, 12/1/1997
  • Join now to see all

Lectures

  • Meeting the Challenges of Parkinson’s disease in Our Community 
    Ellicott City, MD - 4/1/2008
  • Parkinson’s disease: Current management 
    Brown University, Providence, RI - 11/11/2006
  • ACP-103 for drug-induced psychosis: Update on clinical trial 
    San Diego, CA - 4/1/2006
  • Join now to see all

Dr. Susanne Goldstein, Dr. Susanne Goldstein, MD, Dr. S Goldstein, Dr. Susanne Rachel Goldstein